The Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP) was held at the Fairmont Scottsdale Princess on May 28-31, 2019. The committee welcomed submissions from the U.S. as well as international proposals, and this year the committee strongly encouraged the composition of panels and workshops that include women, under-represented minorities and early career scientists and clinicians.
The Program Committee is especially interested in proposals on the topics below, but welcomes all submissions:
Translational Research into Clinical Practice
Patient-focused Drug Development
Use of Biomarkers in RCTs
Technology Advancements and Potential for Assessing Behavior
Use of Personalized Devices and/or Apps
Changes in Digital Phenotyping or Analytical Approaches to Data
Ethical or Privacy Concerns in Behavioral Research
The ASCP Annual Meeting was held from May 28 - 31, 2019 in Scottsdale, Arizona, at the Fairmont Scottsdale Princess. The meeting included representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.
A Steering Committee chaired by Drs. Susan Kornstein and John W. Newcomer with representation of the sectors that are part of the ASCP community lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, and academia comprise the 2019 Steering Committee. A Program Committee under the leadership of Drs. Anita Clayton and Erika Saunders are responsible for review of all program submissions.
After May 21, 2019
New Investigator Alumni ♦
Trainee / Student
FDA / EMA
* All registration types will be verified upon submission of your registration and are subject to change if incorrectly selected. ♦ The NIA Alumni rate is only valid for 7 years after the NIA award is received (2012 through 2018).
REGISTRATION CANCELLATION POLICY Meeting registration refunds in writing were accepted until April 26, 2019. A $75 cancellation fee will be assessed. Refunds are processed within 30 days after receiving a written request. No refunds were given after April 27, 2019.
Registration Descriptions - All registration types will be verified upon submission of your registration and are subject to change if incorrectly selected.
ASCP Full Membership is limited to physician practitioners of psychopharmacology (M.D. or D.O.) and holders of other doctoral degrees who are investigators of clinical psychopharmacology or pharmacology.
Associate Membershipis offered to clinicians or clinician/researchers (non-M.D.; non-D.O.; non-Ph.D.) in the field.
Academic / Clinician is for those attendees who are employed by an academic institution or are full-time practicing clinicians in a private practice or not-for-profit organization.
Government is for attendees who are employed by a government agency.
Industry is for attendees who are part-time or full-time employees with a for-profit research organization.
Fully Retired is for attendees that do not see patients and have no income from other sources (including honoraria from companies, etc.).
New Investigator Alumni is for past New Investigator Awardees. This is only valid for 7 years after the NIA award is received (NIAs from 2012-2018).
Trainee and Student registration is for those attendees who are in a training position (not a full time permanent position). To qualify for the Trainee / Student rate, the attendee MUST submit a letter from their training director or department head verifying that they are in an approved psychiatric residency program with a specified end date.
The 2019 ASCP Annual Meeting took place at the Fairmont Scottsdale Princess, May 28 - 31, 2019. To review the 2019 meeting scheudule and speakers, please log in to your account.
You must login to access 2018 Annual Meeting information.